Research
L-Leucine — living evidence map
The Atlas page holds the claims; this is how its evidence evolved.
Summary
Leucine is used as an excipient in spray-dried powders for inhalation, where it enhances aerosolization and the physical stability of the particles. · pmid:33872799
Identity
PubChem CID 6106: L-Leucine, C6H13NO2, 131.17 g/mol. · pubchem:6106
CAS registry number 61-90-5. · pubchem:6106
IUPAC name: (2S)-2-amino-4-methylpentanoic acid. · pubchem:6106
Where the evidence actually sits
Proportion of the 1 claim about L-Leucine standing at each tier. Community volume is shown on the Consensus tab beside this and is never averaged into it.
Living evidence history
1 resolved citation, oldest to newest, coloured by tier. Retractions and contradictions land here as they are recorded.
Structure
No structure representation on record. PepJunkie draws only what an authoritative record supplies; for a peptide that is the residue sequence, and none has been curated for L-Leucine yet.
Dose evidence, rung by rung
A studied human dose exists on file. Open the rung: the dose is the paper's, in its context, never PepJunkie's.
- Approved-label dose · a resolved regulatory document names a labelled dose
nothing resolved on this rung
- Studied human doses · resolved human studies at the established tier
- Leucine as an excipient in spray dried powder for inhalation. · pmid 33872799 · 2021
- Observational evidence · resolved human data at the emerging tier: thin, or contested
nothing resolved on this rung
- Community-reported protocols · protocol propositions from distinct members, counted once per human
nothing resolved on this rung
- Preclinical evidence · resolved animal, cell or mechanistic work
nothing resolved on this rung
1 resolved citation, 0 unresolved (an unresolved citation lends nothing). Community volume is its own rung and is never averaged into the evidence rungs.